Lung Cancer

Recommendations to Safeguard Quality Shared Decision-Making for Lung Cancer Screening

September 8th 2022, 3:00pm

An updated national coverage determination from CMS about lung cancer screening has some stakeholders concerned that the quality of decision-making tools used by providers and patients may weaken.

Dr Hatim Husain: Biomarker Testing Is a Treatment Cornerstone in NSCLC

August 29th 2022, 5:07pm

Hatim Husain, MD, associate professor in the Department of Medicine at UC San Diego, discuses must-haves for successful biomarker testing in lung cancer—in particular, non–small cell lung cancer (NSCLC)—and how the field is adapting to the targeted treatment needs of its patients.

Clinicians Slow to Adopt PD-1, PD-L1 Inhibitors in NSCLC

August 23rd 2022, 10:42pm

A significant subset of patients continues to receive chemotherapy monotherapy despite the availability of newer approaches, including programmed cell death protein-1 (PD-1) and programmed death ligand-1 (PD-L1) inhibitors.

Evaluating and Integrating New Data Into NSCLC Clinical Pathways

August 18th 2022, 5:56pm

Edward Arrowsmith, MD, concludes with his thoughts on developing therapies and how they are implemented into clinical pathways for NSCLC treatment.

Immune Checkpoint Inhibitors in NSCLC Therapy

August 18th 2022, 5:52pm

Dr Arrowsmith discusses the role immune checkpoint inhibitors play in NSCLC therapy, both as monotherapy and in combination therapy.

HER2m NSCLC an “Exciting Area of Active Investigation,” Says Dr Ticiana Leal

August 17th 2022, 1:36pm

Results from DESTINY-Lung01 have shown promising progression-free survival and overall survival with ongoing research that may lead to a future FDA approval in non–small cell lung cancer (NSCLC), said Ticiana Leal, MD, associate professor, director of the Thoracic Medical Oncology Program, Department of Hematology and Medical Oncology, Emory University School of Medicine.

Trilaciclib Before Chemotherapy May Prevent Hematological Events—With Savings

August 16th 2022, 7:36pm

Caregivers of Patients With Early-Stage Lung Cancer Face Anxiety, Moderate Burden

August 15th 2022, 11:29am

Health care providers can help alleviate caregiver burdens by teaching coping strategies, the authors said.

Targeted Outreach Efforts Meaningful for Patients With Lung Cancer

August 12th 2022, 1:13pm

Patients were more likely to accept intervention from a psychologist if they received regular questionnaires.

NSCLC Outcomes: Clinical and Non-Clinical Evidence

August 8th 2022, 8:56pm

An oncology expert explains how clinical and non-clinical evidence impact the clinical pathway decision-making for patients with NSCLC.